Advances in Chronic Kidney Disease
Volume 11, Issue 4 , Pages 377-386 , October 2004

Rationale for growth hormone therapy in children with chronic kidney disease

  • Larry A. Greenbaum

      Affiliations

    • Medical College of Wisconsin and the Children’s Research Institute of the Children’s Hospital of Wisconsin, Milwaukee, Wisconsin, USA
    • Corresponding Author InformationAddress correspondence to Larry A. Greenbaum, MD, PhD, Medical College of Wisconsin, Department of Pediatrics, 8701 Watertown Plank Rd, Milwaukee, WI 53226
    • Dr. Greenbaum and Dr. Kaskel have served as consultants for Genentech, Inc.
    • ,
  • Marcela Del Rio

      Affiliations

    • Children’s Hospital at Montefiore, Section of Nephrology, Albert Einstein College of Medicine of Yeshiva University, Bronx, New York, USA
    • ,
  • Fatai Bamgbola

      Affiliations

    • Section of Nephrology, Oklahoma University Health Science Center, Oklahoma City, Oklahoma, USA
    • ,
  • Frederick Kaskel

      Affiliations

    • Children’s Hospital at Montefiore, Section of Nephrology, Albert Einstein College of Medicine of Yeshiva University, Bronx, New York, USA
    • Dr. Greenbaum and Dr. Kaskel have served as consultants for Genentech, Inc.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

PII: S1548-5595(04)00118-1

doi: 10.1053/j.ackd.2004.07.005

Advances in Chronic Kidney Disease
Volume 11, Issue 4 , Pages 377-386 , October 2004

Article Tools

* Image Usage & Resolution